Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Braz. J. Pharm. Sci. (Online) ; 58: e19832, 2022. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1394063

RESUMEN

Abstract Medication reconciliation is a strategy to minimize medication errors at the transition points of care. This study aimed to demonstrate the effectiveness of medication reconciliation in identifying and resolving drug discrepancies in the admission of adult patients to a university hospital. The study was carried out in a 300-bed large general public hospital, in which a reconciled list was created between drugs prescribed at admission and those used at pre-admission, adapting prescriptions from the pharmacotherapeutic guidelines of the hospital studied and the patients' clinical conditions. One hundred seven patients were included, of which 67,3% were women, with a mean age of 56 years. Two hundred twenty-nine discrepancies were found in 92 patients; of these, 21.4% were unintentional in 31.8% of patients. The pharmacist performed 49 interventions, and 47 were accepted. Medication omission was the highest occurrence (63.2%), followed by a different dose (24.5%). Thirteen (26.5%) of the 49 unintentional discrepancies included high-alert medications according to ISMP Brazil classification. Medication reconciliation emerges as an important opportunity for the review of pharmacotherapy at transition points of care, based on the high number of unintentional discrepancies identified and resolved. During the drug reconciliation process, the interventions prevented the drugs from being misused or omitted during the patient's hospitalization and possibly after discharge.


Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Adulto , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años , Adulto Joven , Conciliación de Medicamentos/métodos , Hospitales Universitarios , Servicios Farmacéuticos , Preparaciones Farmacéuticas/administración & dosificación , Prescripciones/normas , Seguridad del Paciente , Errores de Medicación/prevención & control
2.
Rev Assoc Med Bras (1992) ; 57(1): 42-5, 2011.
Artículo en Portugués | MEDLINE | ID: mdl-21390458

RESUMEN

OBJECTIVE: To determine the prevalence of hospital admissions due to ADR in Salvador, Bahia and their outcomes. METHODS: All patients admitted in four Sentinel Hospital (ANVISA) in Salvador-Ba were evaluated and followed to determine the prevalence of admissions due to ADR and their outcomes from April to December 2007. Cases were validated by 03 algorithms. The drugs were classified by Anatomical-Therapeutic-Chemical Classification, organs and systems affected by the WHO criteria and severity seconds Pearson et al. Type of ADR was analyzed by Rawlins and Thompson. RESULTS: The prevalence of ADR admission was 0.5% and adjusted for exposed was 2.1%, with 316 cases. Average of hospitalization due to ADR was 12.3 days. Younger and older accounted for 28.8% and 31.1% of patients. Females and blacks were 60% of cases. Main pharmacologic groups were antineoplastics, antibiotics and diuretics, affecting skin, gastrointestinal and hematologic systems. Around 70% of the ADR was validated as defined. ADR of type A was 80% and 90% recovered, and one death (0.5%). CONCLUSION: The prevalence of ADR admission was similar to those described in the literature and only one patient died. As this is the first national study will form the basis for future investigations.


Asunto(s)
Sistemas de Registro de Reacción Adversa a Medicamentos/estadística & datos numéricos , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos , Admisión del Paciente/estadística & datos numéricos , Adolescente , Adulto , Brasil , Niño , Preescolar , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Farmacoepidemiología , Estudios Prospectivos , Adulto Joven
3.
Rev. Assoc. Med. Bras. (1992) ; 57(1): 42-45, jan.-fev. 2011. tab
Artículo en Portugués | LILACS | ID: lil-576150

RESUMEN

OBJETIVO: Determinar a prevalência de admissão por RAM em hospitais de Salvador-BA e seus desfechos. MÉTODOS: Todos os pacientes admitidos nos quatro hospitais sentinela da Anvisa em Salvador-BA foram avaliados e seguidos para determinar a prevalência de admissão por RAM e seus desfechos de abril a dezembro de 2007. Os casos foram validados por três algorítmos. Os medicamentos foram classificados pelo Anatomical-Therapeutic-Chemical Classification, órgãos e sistemas afetados pelos critérios da OMS e a gravidade segundo Pearson et al. O tipo seguiu critérios de Rawlins e Thompson. RESULTADOS: A prevalência de admissão por RAM foi 0,56 por cento e corrigida (expostos) de 2,1 por cento, com 316 casos. Tempo médio de hospitalização por RAM foi de 12,3 dias. Jovens e idosos representaram 28,8 por cento e 31,1 por cento dos pacientes. Gênero feminino e raça negra corresponderam a 60 por cento dos casos. Os principais grupos farmacológicos envolvidos foram antineoplásicos, antibióticos e diuréticos, afetando pele, sistema gastrointestinal e hematológico. Reações certas ou provadas corresponderam 70 por cento, 80 por cento dos casos foram do tipo A, com 90 por cento recuperáveis e um óbito. CONCLUSÃO: A prevalência de admissão por RAM foi semelhante às descritas na literatura e somente um paciente foi a óbito. Por tratar-se do primeiro estudo nacional, servirá de base para futuras investigações.


OBJECTIVE: To determine the prevalence of hospital admissions due to ADR in Salvador, Bahia and their outcomes. METHODS: All patients admitted in four Sentinel Hospital (ANVISA) in Salvador-Ba were evaluated and followed to determine the prevalence of admissions due to ADR and their outcomes from April to December 2007. Cases were validated by 03 algorithms. The drugs were classified by Anatomical-Therapeutic-Chemical Classification, organs and systems affected by the WHO criteria and severity seconds Pearson et al. Type of ADR was analyzed by Rawlins and Thompson. RESULTS: The prevalence of ADR admission was 0.5 percent and adjusted for exposed was 2.1 percent, with 316 cases. Average of hospitalization due to ADR was 12.3 days. Younger and older accounted for 28.8 percent and 31.1 percent of patients. Females and blacks were 60 percent of cases. Main pharmacologic groups were antineoplastics, antibiotics and diuretics, affecting skin, gastrointestinal and hematologic systems. Around 70 percent of the ADR was validated as defined. ADR of type A was 80 percent and 90 percent recovered, and one death (0.5 percent). CONCLUSION: The prevalence of ADR admission was similar to those described in the literature and only one patient died. As this is the first national study will form the basis for future investigations.


Asunto(s)
Adolescente , Adulto , Niño , Preescolar , Femenino , Humanos , Lactante , Recién Nacido , Persona de Mediana Edad , Adulto Joven , Sistemas de Registro de Reacción Adversa a Medicamentos/estadística & datos numéricos , Admisión del Paciente/estadística & datos numéricos , Preparaciones Farmacéuticas/efectos adversos , Brasil , Farmacoepidemiología , Estudios Prospectivos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...